Patient leaflet - Spevigo 150 mg solution for injection in Pre-filled syringe
What Spevigo is used for
Spevigo is used in adults and adolescents from of age to prevent flares of a rare inflammatory s disease called generalised pustular psoriasis (GP During a flare, patients may experience painful s blisters that develop suddenly over large areas o skin. These blisters, also called pustules, are fill pus. The skin may become red, itchy, dry, cracke scaly. Patients may also experience more general and symptoms, such as fever, headache, extrem tiredness, or a burning sensation of the skin. Spevigo clears pustules and other skin manifest and can therefore help to reduce the signs and symptoms of your disease.
12 years kin
P).
kin
f the
ed with d or
signs
e
ations
2. What you need to know before you us Spevigo
A doctor experienced in treating patients with inflammatory skin diseases will start and super your treatment.
Do not use Spevigo if you:
- are allergic to spesolimab or any of the other in of this medicine (listed in section 6).
- have active tuberculosis or other severe infect (see “Warnings and precautions”).
Warnings and precautions
e
vise
gredients
ions
Talk to your doctor or nurse before and during t Spevigo if you:
- currently have an infection or have an infectio keeps coming back. Fever, flu-like symptoms, ti or shortness of breath, a cough which will not warm, red and painful skin, or a painful rash w blisters can be signs and symptoms of an infe
- have, have had tuberculosis, or have been in c contact with someone with tuberculosis.
have recently had a vaccination or plan to have a vaccination. You should not be given certain of vaccines (live vaccines) for at least 16 week being given Spevigo. Your doctor will check if need any vaccines before you start using Spev
he use of
n that
redness go away, ith
ction.
lose
types s after
you
igo.
- experience symptoms like weakness in your a legs that was not there before or numbness (lo sensation), tingling or a burning sensation in of your body. These might be signs of peripher neuropathy (damage of the peripheral nerves)
It is important to keep a record of the batch nu your Spevigo.
Every time you get a new pack of Spevigo, note the date and the batch number (which is on the p after “Lot”) and keep this information in a safe
Infections
Tell your doctor as soon as possible if you notic signs or symptoms of an infection while you are
rms or ss of
any part al
.
mber of
down ackaging place.
e any
using
Spevigo, see section 4 “Possible side effects”.
Allergic reactions
Seek medical help immediately if you notice any signs or symptoms of an allergic reaction while you are using or after you have used this medicine. You can also have allergic reactions some days or weeks after starting the use of Spevigo. For signs and symptoms see section 4 “Possible side effects”.
Children and adoles
Spevigo is not recomm
cents
ended for children under 12 years
of age because it has n
Other medicines and
Tell your doctor if you
- taking, have recently medicines.
- going to have or have should not be given vaccines) for at least
If you are not sure, talk nurse before and durin
Pregnancy and breas
Pregnancy
If you are pregnant, thi
ot been studied in this age group.
Spevigo
are:
taken or might take any other
recently had a vaccination. You certain types of vaccines (live 16 weeks after receiving Spevigo.
to your doctor, pharmacist or g the use of Spevigo.
t-feeding
nk you may be pregnant or are
planning to have a bab before using this medi known how this medic
It is therefore preferab during pregnancy. If you are pregnant, yo medicine if your docto
Breast-feeding
It is not known whethe Spevigo may pass into birth. You should there breast-feeding or plan doctor can decide if yo
y, ask your doctor for advice cine. This is because it is not ine will affect the baby.
le to avoid the use of Spevigo
u should only receive this r has clearly recommended it.
r Spevigo passes into breast milk. breast milk in the first days after fore tell your doctor if you are to breast-feed, so you and your u can use Spevigo.
Driving and using m
Spevigo is not expecte and use machines.
Spevigo contains po
This medicine contain each 1 mL pre-filled sy allergic reactions. Tell y allergies.
Spevigo contains so
This medicine contain (23 mg) per dose, that
achines
d to affect your ability to drive
lysorbate
s 0.4 mg of polysorbate 20 in ringe. Polysorbates may cause our doctor if you have any known
dium
s less than 1 mmol sodium is to say essentially ‘sodium free’.
3. How to use Spev
Always use this medici pharmacist has told yo pharmacist if you are n
How much Spevigo to
Adults and adolescent weighing at least 40 kg
How much 1st dose 600 mg (fo
150 mg inj Further 300 mg (tw
igo
ne exactly as your doctor or u. Check with your doctor or ot sure.
use
s from 12 years of age and
? When?
ur
ections)
When your doctor tells you
o Every 4 weeks starting
doses 150 mg inj
The first dose should b
ections)
after the 1st dose
e given by your doctor or nurse.
You and your doctor or
nurse will decide if you should
inject this medicine yo
urself. Do not inject yourself with
this medicine unless y
ou have been trained by your
doctor or nurse. A care
giver may also give your
injections after they ha
ve been trained.
Read the ‘Instructions
for use’ at the end of this leaflet
before injecting Spevi
go yourself.
Adolescents from 12 y
ears of age weighing 30 to less
than 40 kg
How
much?
When?
1st dose
300 m 150 m
g (two
g injections)
When your doctor tells you
Further doses
150 m 150 m
g (one
g injection)
Every 4 weeks starting after the 1st dose
Spevigo should be given by your doctor or nurse.
If you use more Spevigo than you should
If you have used more Spevigo than you should or the dose has been given sooner than prescribed, talk to your doctor.
If you forget to use Spevigo
If you forget to use Spevigo, inject a dose as soon as you realise. Talk to your doctor if you are not sure what to do.
If you stop using Spevigo
Do not stop using Spevigo without talking to your doctor
firs bac
If y me
4.
Lik alt
See or s you• d
t. If you stop treatment, your symptoms m k or you may experience a flare.
ou have any further questions on the use dicine, ask your doctor, pharmacist, or nur
Possible side effects
e all medicines, this medicine can cause si hough not everybody gets them.
k medical help immediately if you notice ymptoms of an allergic reaction while usi have used this medicine. These may incl ifficulty breathing or swallowing
ay come
of this
se.
de effects,
any signs ng or after
ude:
s• s
b• fe
You aft
See
wid and me rea
Tel sig
welling of the face, lips, tongue or throat evere itching of the skin, with a red rash or umps, that is different from your GPP sym eling faint.
can also have allergic reactions some da er you have used Spevigo.
k medical help immediately if you develo espread skin rash that was not there befo /or facial swelling 2-8 weeks after you ha dicine. These might be signs of a delayed ction (hypersensitivity).
l your doctor as soon as possible if you no ns or symptoms of an infection. These ma
raised
ptoms
ys or weeks
p any
re, fever, ve used the allergic
tice any
y include:
Ver• fe
Co• fr b in
Tell oth
Ver• re o it
y common (may affect more than 1 in 10 ver, cough
mmon (may affect up to 1 in 10 people) equent urination, pain or burning while ur loody urine, which may be symptoms of u fections
your doctor or nurse if you get any of the er side effects:
y common (may affect more than 1 in 10 dness, swelling, hardening, warmth, pain, f the skin, small, solid raised bumps on th ching, skin rash, or hives at the injection s
people)
inating or rinary tract
following
people)
peeling e skin,
ite
Co• it• fe
No
ava
- a
Re
If y Thi lea det pro me
mmon (may affect up to 1 in 10 people) ching
eling tired
t known (frequency cannot be estimated f ilable data)
llergic reaction
porting of side effects
ou get any side effects, talk to your doctor s includes any possible side effects not lis flet. You can also report side effects direct ails below). By reporting side effects you c vide more information on the safety of thi dicine.
rom the
or nurse. ted in this ly (see
an help s
Yell We MH
- 5. Kee chi
Do
sta The
Sto not
ow Card Scheme
bsite: www.mhra.gov.uk/yellowcard or sea RA Yellow Card in the Google Play or Appl
How to store Spevigo
p this medicine out of the sight and reach ldren.
not use this medicine after the expiry date ted on the pre-filled syringe and the carto expiry date refers to the last day of that m
re in a refrigerator (2 °C – 8 °C). Do not fre use Spevigo if frozen, even if it has been
rch for
e App Store
of
which is n after EXP. onth.
eze. Do
thawed.
If n
eeded, Spevigo can be stored at temperat
ures up to
25
°C for up to 14 days. Throw away Spevigo i
f it has
bee
n kept at temperatures up to 25 °C for mo
re than
14
days.
Sto
re in the original package in order to prote
ct from
ligh
t.
Do
not use this medicine if the liquid is cloud
y or
con
tains flakes or large or coloured particles.
Do
not throw away any medicines via wastew
ater or
ho
usehold waste. Ask your pharmacist how t
o throw
aw
ay medicines you no longer use. These me
asures will
hel
p protect the environment.
6. Contents of the pack and other information
What Spevigo contains
- The active substance is spesolimab. Each pre-filled syringe contains 150 mg spesolimab in 1 mL solution.
The other ingredients are sodium acetate trihydrate (E262), glacial acetic acid (E260) (for pH adjustment), sucrose, arginine hydrochloride, polysorbate 20 (E432) and water for injections.
What Spevigo looks like and contents of the pack
Spevigo solution for injection is a clear to slightly opalescent, colourless to slightly brownish-yellow solution in a pre-filled syringe with safety cover. The liquid may contain tiny white or clear particles. Each pre-filled syringe contains 150 mg in 1 mL solution for injection.
Each pack contains 2 pre-filled syringes.
Marketing Authorisation Holder
Boehringer Ingelheim Inte Binger Str. 173
55216 Ingelheim am Rhei Germany
Manufacturer
Boehringer Ingelheim Pha Birkendorfer Strasse 65 88397 Biberach an der Ris Germany
For any information abou the local representative of Holder:
rnational GmbH n rma GmbH & Co. KG s t this medicine, please contact the Marketing Authorisation
United Kingdom
Boehringer Ingelheim Ltd. Tel: +44 1344 424 600
This leaflet was last revise
d in 09/2025.
Package leaflet: Information for the patient
Spevigo® 150 mg ABCD solution for injection
in pre-filled syringe
spesolimab
This medicine is subject to additional monitorin
by reporting any side effects you may get. See th
Read all of this leaflet carefully, because it c
- Keep this leaflet. You may need to read it agai
- If you have any further questions, ask your do
If you get any side effects, talk to your doctor o See section 4.
g. This will allow quick identification of e end of section 4 for how to report sid
ontains important information f
n.
ctor or nurse.
r nurse. This includes any possible sid
new safety information. You can help e effects.
or you.
e effects not listed in this leaflet.
A
B C
| File information | ||||||
| Issue date of TD: | ||||||
Perigord No: 904002 P2
Yes Yes No Yes No Yes No Yes No No Yes Yes TD Printfile Mandatory in | ||||||
| 07.10.2024 | ||||||
| PPM SKU: P058761 | ||||||
| PPM SKU version: 003 | ||||||
| Print colors: BLACK | CYAN | MAGENTA | ||||
| YELLOW | ||||||
| Mat. No. Pack. Site: P058761-003 | ||||||
| Legend case version: V5.0 01/Jan/2021 (please do not change or remove it) | ||||||
| Additional Requirements of Packaging site | |
| Template name: PI_680x475_70x60 | Index: 5.0 |
MASS A 25,5 mm MASS B 2,2 mm MASS C max. 44 mm Bleed 3 mm
| Only for BI-internal use, Template according to Drawing no.: SP-14-0101-001-B_Index_ |
Code Type: 128a
In-process control code specification
Spevigo® 150 mg solution for injection in pre-filled syringe
This “Instructions for use” contains information on how to inject Spevigo if the prescribed dose for you or your child requires 2 pre-filled syringes of Spevigo 150 mg.
Getting to know Spevigo
The pre-filled syringe contains the active substance spesolimab in a solution for subcutaneous injection that helps to deliver a fixed dose of spesolimab.
Before you start using this medicine on your own or your child, first make sure that you get trained by your doctor or nurse. Then read the package leaflet and these instructions for use to make sure you get the correct dose. If you are visually impaired and cannot see well, you must be assisted by a trained caregiver.
If you have further questions, ask your doctor, pharmacist or nurse.
Spevigo is for single use. Do not reuse the pre-filled syringe.
This is what Spevigo pre-filled syringe looks like
Spevigo is a pre-filled syringe with a safety cover. The needle is pulled back into the safety cover after injection.
The following picture shows Spevigo before use and after use with the activated safety cover.![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
thumb pad
Before Use
After Use![]()
![]()
![]()
![]()
![]()
![]()
covered needle
activated
safety cover
The needle should be inside the safety cover after use. plunger rod
finger grip
medicine safety cover
cap
syringe
body
Your healthcare professional has prescribed a dose of Spevigo for you or your child that requires two injections to deliver a complete dose. You must inject the contents of both pre-filled syringes that come in the carton to deliver the complete dose.
Important information you need to know before injecting Spevigo
Do not use the pre-filled syringe until you have been shown the right way to give
the injection and have read and understood these handling instructions.
Inspect the carton that the product comes in to be sure that you have the correct
medicine, the correct number of pre-filled syringes for your or your child’s prescribed dose, for any damage, and the expiry date.
- Do not remove the cap until you are ready to inject.
Do not use Spevigo:
- if the liquid is cloudy or contains flakes or large particles.
- if the expiry date (EXP) has passed.
- if the pre-filled syringes have been dropped or look damaged.
It is important to keep a record of the batch number of your Spevigo.
Every time you get a new pack of Spevigo, note down the date and the batch number (which is on the packaging after “Lot”) and keep this information in a safe place.
Inject Spevigo under the skin (subcutaneous injection) in either the upper thighs
or stomach area (abdomen). Do not inject Spevigo into any other area of the body.
If you have any problems with your injection, do not repeat the injection steps
with Spevigo pre-filled syringe. Call your doctor for help.
If you have further questions, ask your doctor or pharmacist.
- Take the Spevigo carton out of the refrigerator and remove the pre-filled syringes from the carton.
- Gather supplies listed on the left side and place them on a clean, flat work surface in a well-lit area.
- If you do not have all the supplies listed, contact your pharmacist.
For disposal, see step 10: “Disposing of the used pre-filled syringes and caps.”
- Clean the injection site with an alcohol wipe and let air dry.
- Do not touch this area again before injecting.
Do not fan or blow on the clean area.
- Hold the pre-filled syringe by the blue finger grip. Avoid touching the blue thumb pad.
- Using a quick, “dart-like” motion, insert the needle into the pinched skin at about a 45-degree angle.
- Do not move the needle while inserting or during the injection.
Important: Do not move the pre-filled syringe when inserting the needle into your skin, while injecting, or when removing the needle from your skin.
- Put the used pre-filled syringes and caps in a sharps disposal container right away after use.
- Do not throw away the pre-filled syringes in the household waste.
- Your doctor, pharmacist, or nurse will tell you how to return the full sharps disposal container.
- Do not reuse the pre-filled syringes. Important: Always keep the sharps disposal container out of the reach of children.
- Choose a different injection site. The new injection site should be at least 2 cm away from last injection site.
- Take the second pre-filled syringe.
- Repeat steps 4 through 8 right away.
- Then continue to step 10.
Important: You must inject the contents of both Spevigo pre-filled syringes to give a complete dose.
To inject Spevigo:
- Use your thumb to slowly press down on the blue thumb pad to push the plunger rod down inside the syringe body.
- Continue pressing on the blue thumb pad until the plunger rod has moved all the way down.
- Make sure that the blue thumb pad cannot be pressed any further so that the built-in safety cover can be activated.
Slowly remove your thumb from the blue thumb pad, to move the needle out of your skin and up into the safety cover. ° Check that the thumb pad springs back and that the needle is inside the safety cover.
° If the needle is not inside the safety cover call your doctor. You may not have received a full dose.
- If there is bleeding, press a cotton ball or gauze on the site for a few seconds.
- Do not rub the injection site.
- Apply a plaster if needed.
Hold the pre-filled syringe by the finger grip with one hand. With the other hand, pull the cap straight off.
° Do not pull on or hold the plunger rod. ° Do not twist the cap. Twisting the cap
could damage the needle.
° Do not use the prefilled syringe if the
needle is bent or damaged. If you accidentally bend the needle, do not attempt to straighten it.
- Put the cap aside.
Use right away after removing the cap. ° Do not try to recap the needle.
Re-capping can lead to needle-stick injury.
° Do not touch the needle or let the needle
touch anything before injecting.
- Gently pinch the area of cleaned skin around your injection site and hold it firmly.
- Keep the skin pinched during the entire injection. You will inject into the pinched skin.
- Do not let go until you have removed the needle from your skin at the end of the injection.
- Wait 15 to 30 minutes to allow the medicine to reach room temperature to avoid discomfort during injection. Do not speed up the warming process in any way, such as using the microwave or placing the syringe in warm water.
- Do not leave the pre-filled syringes in direct sunlight.
- Wash your hands well with soap and water and dry them.
Check both pre-filled syringes now:
- Check to make sure the medicine name and dose on the pre-filled syringes match your or your child’s prescription.
- Check the expiry date (EXP) on both pre-filled syringes. Do not use if the expiry date has passed.
- Check both pre-filled syringes for damage, cracks, and leakage. Do not use if any part of the pre-filled syringes appears cracked, broken, or is leaking.
- Make sure the medicine in both pre-filled syringes is colourless to slightly yellow. It may contain tiny white or clear particles. Do not use if the medicine is cloudy or has flakes or large particles in it.
- It is normal to see air bubbles, they do not need to be removed.
- Do not use if the Spevigo pre-filled syringes have been dropped.
Prepare for the first of two injections. Remember, you will repeat the following steps with the second pre-filled syringe right away after your first injection. Two injections are needed for a complete dose.
Choose an injection site.
You may use an area on your:
° upper thighs or
° stomach area (abdomen), except for an
area 5 cm around your navel (belly button).
- Choose a different injection site each time you inject, at least 2 cm away from the last injection site.
- Do not inject into an area near your waistline or belly button.
- Do not inject into areas that are tender, bruised, red, hard, or scarred.
- Do not inject through clothes.
Instructions for use
abcd
STEP 1
Gathering supplies
15-30
minutes
Bring medicine to room temperature
Wash hands
EXP MM YYYY
Injection areas
Abdomen
Upper thighs
2 Spevigo pre-filled syringes
2 cotton balls or gauze
(not included)
2 alcohol wipes
(not included)
1 sharps disposal container
(not included)
STEP 2
Preparing to inject Spevigo
STEP 3
Inspecting the pre-filled syringes
Preparing for your first injection
STEP 4
Choosing the injection site
STEP 5
Cleaning the injection site
STEP 6
Removing the cap
STEP 7
Pinch the skin
STEP 8
Before injecting, review steps A, B, and C to learn the correct way to inject
STEP 10
Disposing of the used pre-filled syringes and caps
STEP 9
Second injection
A Inserting the needle
P058761-003 Follow the steps below when you use Spevigo
Cap
B Injecting the medicine
Push firmly
45°
C Checking injection is complete
Remove thumb to activate the safety cover
45° 45°
medicine
Check both pre-filled syringes now
